Earnings History Data for Applied Therapeutics (APLT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Applied Therapeutics
Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet medical need. The company's product candidate consists of AT-001, for the treatment of Diabetic Cardiomyopathy; AT-007, for the treatment of Galactosemia and AT-003, for the treatment of diabetic retinopathy which are in clinical stage. Applied Therapeutics Inc. is based in New York, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | APLT | Applied Therapeutics | 1,106 | -0.20 | -0.13 | 0.00 | Applied Therapeutics GAAP EPS of -$0.48, revenue of $0.12M [11/7/2024 9:35 AM] |
9.74 | 0.09 (0.98%) |
9.53 | -0.12 (-1.24%) |
1.79 - 9.98 | 1,097,773 | 1,730,000 | 1,293 | ||
| 07-08-2024 | PM | APLT | Applied Therapeutics | 687.00 | -0.13 | -0.10 | 0.00 | Applied Therapeutics GAAP EPS of -$0.13 [8/7/2024 9:22 AM] |
6.21 | 0.11 (1.72%) |
6.27 | 0.17 (2.79%) |
1.18 - 9.39 | 1,005,273 | 1,280,000 | 3,073 | ||
| 06-03-2024 | PM | APLT | Applied Therapeutics | 533.00 | -0.33 | -0.15 | 0.00 | Applied Therapeutics GAAP EPS of -$1.42 beats by $0.02, revenue of $10M misses by $0.67M [3/6/2024 7:31 AM] |
6.45 | 0.28 (4.54%) |
6.40 | 0.23 (3.73%) |
0.76 - 9.39 | 1,244,874 | 3,320,000 | 5,493 | ||
| 09-11-2023 | PM | APLT | Applied Therapeutics, Inc. | 147.71 | -0.47 | 0.00 | -0.40 | Applied Therapeutics GAAP EPS of -$0.47 misses by $0.21 [11/9/2023 8:17 AM] |
2.06 | -0.25 (-10.82%) |
2.49 | 0.18 (7.79%) |
0.64 - 3.11 | 868,551 | 490,000 | 1,497 | ||
| 09-11-2022 | PM | APLT | Applied Therapeutics | 35.00 | -0.40 | -0.45 | 0.00 | Applied Therapeutics GAAP EPS of -$0.40 beats by $0.12 [11/9/2022 8:42 AM] |
0.65 | -0.06 (-8.59%) |
0.71 | 0.0 (-0.15%) |
0.50 - 15.66 | 227,189 | 210,000 | 883 | ||
| 12-08-2022 | PM | 7:00 AM ET (Aug 12) |
APLT | Applied Therapeutics, Inc. | 25.90 | -0.80 | 0.00 | -0.99 | Applied Therapeutics GAAP EPS of -$0.96 misses by $0.40 [8/12/2022 8:18 AM] |
1.35 | 0.02 (1.50%) |
1.40 | 0.07 (5.26%) |
0.73 - 19.14 | 219,128 | 230,000 | 2,988 | |
| 12-05-2022 | PM | APLT | Applied Therapeutics | 47.00 | -0.88 | -0.82 | 0.00 | Applied Therapeutics GAAP EPS of -$0.88 [5/12/2022 8:28 AM] |
1.76 | 0.01 (0.57%) |
1.81 | 0.06 (3.43%) |
1.45 - 25.59 | 166,829 | 160,000 | 673 | ||
| 10-03-2022 | PM | 7:00 AM ET (Mar 10) |
APLT | Applied Therapeutics | 45.00 | -1.04 | -1.22 | 0.00 | Applied Therapeutics GAAP EPS of -$4.12 beats by $0.31 [3/10/2022 8:13 AM] |
1.68 | -0.07 (-4.00%) |
1.75 | 0.0 (0.00%) |
0.0 - 0.0 | 100,328 | 0 | 0 | |
| 12-11-2021 | PM | APLT | Applied Therapeutics, Inc. | 389.53 | -1.09 | -0.99 | -1.33 | Applied Therapeutics EPS beats by $0.01 [11/12/2021 7:42 AM] |
14.77 | 0.82 (5.88%) |
13.95 | 0.0 (0.00%) |
13.04 - 29.80 | 27,059 | 90,000 | 635 | ||
| 12-08-2021 | PM | APLT | Applied Therapeutics Inc. | 415.00 | -0.99 | -0.99 | 0.00 | Applied Therapeutics EPS beats by $0.09 [8/12/2021 7:49 AM] |
15.56 | 0.06 (0.39%) |
15.56 | 0.0 (0.00%) |
13.58 - 33.34 | 229,317 | 70,000 | 1,346 | ||
| 11-05-2021 | PM | 7:00 AM ET (May 11) |
APLT | Applied Therapeutics, Inc. | 476.00 | -1.00 | -1.06 | -0.59 | Applied Therapeutics EPS beats by $0.10 [5/11/2021 8:10 AM] |
16.57 | 0.34 (2.09%) |
16.23 | 0.0 (0.00%) |
13.58 - 51.99 | 67,713 | 80,000 | 1,389 | |
| 18-03-2021 | PM | 7:00 AM ET (Mar 18) |
APLT | Applied Therapeutics Inc. | 486.00 | -1.06 | -1.31 | 0.00 | Applied Therapeutics EPS beats by $0.26 [3/18/2021 7:46 AM] |
20.09 | 0.41 (2.08%) |
19.68 | 0.0 (0.00%) |
13.58 - 51.99 | 152,693 | 130,000 | 432 | |
| 12-11-2020 | PM | APLT | Applied Therapeutics, Inc. | 403.39 | -1.33 | -1.04 | -0.63 | Applied Therapeutics EPS misses by $0.21 [11/12/2020 7:21 AM] |
15.50 | 0.0 (0.00%) |
15.66 | 0.16 (1.03%) |
13.99 - 57.39 | 148,537 | 153,226 | 285 | ||
|
|
||||||||||||||||||
| 11-08-2020 | PM | APLT | Applied Therapeutics, Inc. | 594.77 | -1.27 | -0.72 | -0.60 | Applied Therapeutics EPS misses by $0.56 [8/11/2020 7:13 AM] |
28.90 | 1.95 (7.24%) |
26.95 | 0.0 (0.00%) |
8.55 - 57.39 | 141,361 | 181,198 | 634 | ||
|
|
||||||||||||||||||